Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 15/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7326447 | 0.84 | KIF11 (0.47) | KIF11CYP1A2CYP2C19HIF1ASLC1A5 | |
| SCHEMBL7318407 | 0.82 | KIF11 (0.59) | KIF11CYP1A2CYP2C19HIF1ASLC1A5 | |
| SCHEMBL7314907 | 0.80 | KIF11 (0.55) | KIF11CYP1A2CYP2C19HIF1ASLC1A3 | |
| SCHEMBL7323114 | 0.80 | KIF11 (0.55) | KIF11CYP1A2CYP2C19HIF1ASLC1A3 | |
| SCHEMBL7316648 | 0.77 | KIF11 (0.42) | KIF11CYP1A2CYP2C19HIF1ASLC1A3 | |
| SCHEMBL7325201 | 0.75 | CYP1A2 (0.59) | KIF11CYP1A2CYP2C19HIF1ASLC1A5 | |
| SCHEMBL7326122 | 0.75 | KIF11 (0.59) | KIF11CYP1A2CYP2C19HIF1ASLC1A5 | |
| SCHEMBL7325243 | 0.74 | KIF11 (0.42) | KIF11CYP1A2CYP2C19HIF1ASLC1A3 | |
| SCHEMBL7313597 | 0.74 | KIF11 (0.49) | KIF11CYP1A2CYP2C19HIF1ASLC1A3 | |
| SCHEMBL7314762 | 0.73 | KIF11 (0.51) | KIF11SLC1A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | claimed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |
| WO-1999041227-A1 | TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-08-19 | — | — | WO | disclosed |